e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic–polycytidylic acid-induced pneumonia
Chang Seok Lee, Eun Hee Yi, Jin-Ku Lee, Cheolhee Won, Young Ju Lee, Min Kyung Shin, Young Mok Yang, Myung-Hee Chung, Jung Weon Lee, Sang-Hyun Sung, Sang-Kyu Ye
Source:
Eur Respir J 2013; 41: 1147-1156
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chang Seok Lee, Eun Hee Yi, Jin-Ku Lee, Cheolhee Won, Young Ju Lee, Min Kyung Shin, Young Mok Yang, Myung-Hee Chung, Jung Weon Lee, Sang-Hyun Sung, Sang-Kyu Ye. Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic–polycytidylic acid-induced pneumonia. Eur Respir J 2013; 41: 1147-1156
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Cytoplasmic signaling of polyinosinic-polycytidylic acid stimulates a quick and potent interferon response in primary macrophages
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
Monocyte chemotactic protein-1 in the migration of differentiated leukaemic cells toward alveolar epithelial cells
Source: Eur Respir J 2008; 31: 957-962
Year: 2008
Effects of extracellular Hsp70, lipoteichoic acid and lipopolysaccharide on TLR2 and TLR4 mRNA expression in monocyte-derived macrophages
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
Increased expression of microRNA-146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Thrombin activates mitogen activated protein (MAP) kinase and activated protein-1 (AP-1) to induce interleukin-8 (IL-8) release from airway epithelial cells
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003
Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils
Source: Eur Respir J 2001; 18: Suppl. 33, 161s
Year: 2001
Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Double-stranded RNA upregulates TLR3 and induces pro-inflammatory, and innate immune cytokine expression in human bronchial smooth muscle cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010
Secretory leucoprotease inhibitor (SLPI) inhibits IL-8 expression induced by double-stranded RNA in airway epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005
A CXCR2 antagonist inhibits polyI:C-induced airway neutrophil, but not lymphocyte infiltrate
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells
Source: Eur Respir J 2005; 26: 795-803
Year: 2005
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9
Source: Eur Respir J 2002; 20: 1198-1205
Year: 2002
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients?
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Remifentanil attenuates LPS-induced neutrophil activation
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept